Though the approach to 17,730 exposed vulnerability on anticipated lines, upside prospects, remain alive as long as above 17,550 on a closing basis, Anand James – Chief Market Strategist at Geojit Financial Services, said.
The Nifty Pharma index gained around 2% on Tuesday, defying the broader market trend, as the Nifty slipped nearly 0.5% amid profit-booking following Monday’s sharp
Operation Sindoor not only served as retaliation for the Pakistan-sponsored terror attack but also provided a rare platform for India to demonstrate its military prowess.
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003